Clin Endosc.  2022 Mar;55(2):234-239. 10.5946/ce.2021.126.

Propofol Alone versus Propofol in Combination with Midazolam for Sedative Endoscopy in Patients with Paradoxical Reactions to Midazolam

• Nam JH
• Jang DK
• Lee JK
• Kang HW
• Kim BW
• Jang BI
• the Committees of Quality Management and Conscious Sedation of Korean Society of Gastrointestinal Endoscopy (KSGE)

• KMID: 2527567
• DOI: http://doi.org/10.5946/ce.2021.126

Abstract

Background/Aims
The efficacy of propofol in gastrointestinal endoscopy for patients with midazolam-induced paradoxical reactions remains unclarified. This study aimed to compare the efficacy and safety of propofol-based sedation in patients who previously experienced paradoxical reactions.
Methods
This was a prospective, single-blinded, randomized controlled pilot study. Participants with a history of paradoxical reactions to midazolam during a previous esophagogastroduodenoscopy were recruited and randomly assigned to group I (propofol monosedation) or group II (combination of propofol and midazolam). The primary endpoint was the occurrence of a paradoxical reaction.
Results
A total of 30 participants (mean age, 54.7±12.6 years; male, 19/30) were randomly assigned to group I (n=16) or group II (n=14). There were no paradoxical reactions in group I, but there were two in group II, without a significant difference (p=0.209). The mean dose of propofol was higher in group I than in group II (p=0.002). Meanwhile, the procedure and recovery times did not differ between groups.
Conclusions
Propofol-based sedation was safe and effective for patients who experienced paradoxical reactions to midazolam. However, caution is needed because few cases of paradoxical reaction again can happen in group II in which midazolam was readministered.

Keyword

Endoscopy; Midazolam; Paradoxical reaction; Propofol; Sedation

Figure

• 

  Fig. 1. Study flow. EGD, esophagogastroduodenoscopy; IV, intravenous administration.

Reference

1. Yi SY, Shin JE. Midazolam for patients undergoing upper gastrointestinal endoscopy: a prospective, single-blind and randomized study to determine the appropriate amount and time of initiation of endoscopy. J Gastroenterol Hepatol. 2005; 20:1873–1879.

2. Valori R, Cortas G, de Lange T, et al. Performance measures for endoscopy services: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J. 2019; 7:21–44.

3. Lee JK, Lee YJ, Cho JH, et al. Updates on the sedation for gastrointestinal endoscopy. Clin Endosc. 2019; 52:451–457.

4. Tae CH, Kang KJ, Min BH, et al. Paradoxical reaction to midazolam in patients undergoing endoscopy under sedation: incidence, risk factors and the effect of flumazenil. Dig Liver Dis. 2014; 46:710–715.

5. Hong GW, Lee JK, Lee JH, et al. Comparison of fentanyl versus meperidine in combination with midazolam for sedative colonoscopy in Korea. Clin Endosc. 2020; 53:562–567.

6. Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy. 2004; 24:1177–1185.

7. Weinbroum AA, Szold O, Ogorek D, Flaishon R. The midazolam-induced paradox phenomenon is reversible by flumazenil. Epidemiology, patient characteristics and review of the literature. Eur J Anaesthesiol. 2001; 18:789–797.

8. Honan VJ. Paradoxical reaction to midazolam and control with flumazenil. Gastrointest Endosc. 1994; 40:86–88.

9. Rex DK, Deenadayalu VP, Eid E, et al. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology. 2009; 137:1229–1237. quiz 1518-1519.

10. Lee JK, Jang DK, Kim WH, Kim JW, Jang BI. [Safety of non-anesthesiologist administration of propofol for gastrointestinal endoscopy]. Korean J Gastroenterol. 2017; 69:55–58.

11. Levitzky BE, Lopez R, Dumot JA, Vargo JJ. Moderate sedation for elective upper endoscopy with balanced propofol versus fentanyl and midazolam alone: a randomized clinical trial. Endoscopy. 2012; 44:13–20.

12. Poulos JE, Kalogerinis PT, Caudle JN. Propofol compared with combination propofol or midazolam/fentanyl for endoscopy in a community setting. AANA J. 2013; 81:31–36.

13. Khoshoo V, Thoppil D, Landry L, Brown S, Ross G. Propofol versus midazolam plus meperidine for sedation during ambulatory esophagogastroduodenoscopy. J Pediatr Gastroenterol Nutr. 2003; 37:146–149.

14. Lee TH, Lee CK, Park SH, et al. Balanced propofol sedation versus propofol monosedation in therapeutic pancreaticobiliary endoscopic procedures. Dig Dis Sci. 2012; 57:2113–2121.

15. Dumonceau JM, Riphaus A, Aparicio JR, et al. European society of gastrointestinal endoscopy, european society of gastroenterology and endoscopy nurses and associates, and the european society of anaesthesiology guideline: non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy. 2010; 42:960–974.

16. Harris ZP, Liu J, Saltzman JR. Quality assurance in the endoscopy suite: sedation and monitoring. Gastrointest Endosc Clin N Am. 2016; 26:553–562.

17. McGrath B, Chung F. Postoperative recovery and discharge. Anesthesiol Clin North Am. 2003; 21:367–386.

18. Golparvar M, Saghaei M, Sajedi P, Razavi SS. Paradoxical reaction following intravenous midazolam premedication in pediatric patients - a randomized placebo controlled trial of ketamine for rapid tranquilization. Paediatr Anaesth. 2004; 14:924–930.

19. Massanari M, Novitsky J, Reinstein LJ. Paradoxical reactions in children associated with midazolam use during endoscopy. Clin Pediatr (Phila). 1997; 36:681–684.

20. Terui T, Inomata M. Administration of additional analgesics can decrease the incidence of paradoxical reactions in patients under benzodiazepine-induced sedation during endoscopic transpapillary procedures: prospective randomized controlled trial. Dig Endosc. 2013; 25:53–59.

21. Shin S, Oh TG, Chung MJ, et al. Conventional versus analgesia-oriented combination sedation on recovery profiles and satisfaction after ERCP: a randomized trial. PLoS One. 2015; 10:e0138422.

22. VanNatta ME, Rex DK. Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy. Am J Gastroenterol. 2006; 101:2209–2217.

23. Kiriyama S, Naitoh H, Kuwano H. Propofol sedation during endoscopic treatment for early gastric cancer compared to midazolam. World J Gastroenterol. 2014; 20:11985–11990.

24. Kanno Y, Ohira T, Harada Y, et al. Safety and recipient satisfaction of propofol sedation in outpatient endoscopy: a 24-hour prospective investigation using a questionnaire survey. Clin Endosc. 2021; 54:340–347.

25. Cohen LB, Wecsler JS, Gaetano JN, et al. Endoscopic sedation in the United States: results from a nationwide survey. Am J Gastroenterol. 2006; 101:967–974.

26. Park CH, Han DS, Jeong JY, et al. Outcomes of propofol sedation during emergency endoscopy performed for upper gastrointestinal bleeding. Dig Dis Sci. 2016; 61:825–834.

27. Lee SH, Lee GM, Lee DR, Lee JU. Factors related to paradoxical reactions during propofol-induced sedated endoscopy. Scand J Gastroenterol. 2019; 54:371–376.